• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培育人类新肾脏。

Growing a new human kidney.

机构信息

Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, United Kingdom; Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

出版信息

Kidney Int. 2019 Oct;96(4):871-882. doi: 10.1016/j.kint.2019.04.040. Epub 2019 May 25.

DOI:10.1016/j.kint.2019.04.040
PMID:31399199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6856720/
Abstract

There are 3 reasons to generate a new human kidney. The first is to learn more about the biology of the developing and mature organ. The second is to generate tissues with which to model congenital and acquired kidney diseases. In particular, growing human kidneys in this manner ultimately should help us understand the mechanisms of common chronic kidney diseases such as diabetic nephropathy and others featuring fibrosis, as well as nephrotoxicity. The third reason is to provide functional kidney tissues that can be used directly in regenerative medicine therapies. The second and third reasons to grow new human kidneys are especially compelling given the millions of persons worldwide whose lives depend on a functioning kidney transplant or long-term dialysis, as well as those with end-stage renal disease who die prematurely because they are unable to access these treatments. As shown in this review, the aim to create healthy human kidney tissues has been partially realized. Moreover, the technology shows promise in terms of modeling genetic disease. In contrast, barely the first steps have been taken toward modeling nongenetic chronic kidney diseases or using newly grown human kidney tissue for regenerative medicine therapies.

摘要

生成新人类肾脏有 3 个原因。第一个原因是为了更深入地了解发育中和成熟器官的生物学特性。第二个原因是为了生成组织,从而构建先天性和获得性肾脏疾病模型。特别地,通过这种方式生长的人类肾脏最终应该有助于我们理解常见慢性肾脏疾病(如糖尿病肾病和其他纤维化疾病)以及肾毒性的机制。第三个原因是提供可直接用于再生医学治疗的功能性肾脏组织。鉴于全世界有数百万人的生命依赖于功能正常的肾脏移植或长期透析,以及那些因无法获得这些治疗而过早死亡的终末期肾病患者,因此生成新人类肾脏的第二和第三个原因尤其具有吸引力。正如这篇综述所展示的,创造健康的人类肾脏组织的目标已经部分实现。此外,该技术在构建遗传疾病模型方面具有很大的潜力。相比之下,对于构建非遗传慢性肾脏疾病模型,或者对于使用新生长的人类肾脏组织进行再生医学治疗,仅仅迈出了第一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/b76184272eef/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/c94339a2e2c3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/e80617d38b10/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/6623795c0e11/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/89f9b5730d10/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/8199ac3f8d03/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/b76184272eef/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/c94339a2e2c3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/e80617d38b10/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/6623795c0e11/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/89f9b5730d10/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/8199ac3f8d03/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e2f/6856720/b76184272eef/gr6.jpg

相似文献

1
Growing a new human kidney.培育人类新肾脏。
Kidney Int. 2019 Oct;96(4):871-882. doi: 10.1016/j.kint.2019.04.040. Epub 2019 May 25.
2
Regenerative medicine of the kidney.肾脏的再生医学。
Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):379-87. doi: 10.1016/j.addr.2010.12.001. Epub 2010 Dec 9.
3
Repairing the chronic damaged kidney: the role of regenerative medicine.修复慢性损伤肾脏:再生医学的作用
Transplant Proc. 2011 Dec;43(10):3573-6. doi: 10.1016/j.transproceed.2011.10.053.
4
Kidney regeneration and repair after transplantation.移植后的肾脏再生与修复。
Curr Opin Organ Transplant. 2013 Apr;18(2):191-6. doi: 10.1097/MOT.0b013e32835f0771.
5
Regenerative medicine in kidney disease: where we stand and where to go.肾脏疾病中的再生医学:现状与展望。
Pediatr Nephrol. 2018 Sep;33(9):1457-1465. doi: 10.1007/s00467-017-3754-9. Epub 2017 Jul 22.
6
Developmental engineering the kidney: leveraging principles of morphogenesis for renal regeneration.肾脏发育工程:利用形态发生原理实现肾脏再生
Birth Defects Res C Embryo Today. 2012 Mar;96(1):30-8. doi: 10.1002/bdrc.20224.
7
Regenerative strategies for kidney engineering.肾脏工程的再生策略。
FEBS J. 2016 Sep;283(18):3303-24. doi: 10.1111/febs.13704. Epub 2016 Mar 24.
8
Stem cell and regenerative science applications in the development of bioengineering of renal tissue.干细胞与再生科学在肾组织生物工程学发展中的应用。
Pediatr Res. 2008 May;63(5):467-71. doi: 10.1203/PDR.0b013e3181660653.
9
Potential Therapeutic Strategies of Regenerative Medicine for Renal Failure.再生医学治疗肾衰竭的潜在策略
Curr Stem Cell Res Ther. 2017;12(5):423-431. doi: 10.2174/1574888X12666170317163416.
10
Renal Tubular- and Vascular Basement Membranes and their Mimicry in Engineering Vascularized Kidney Tubules.肾管状和血管基底膜及其在工程化血管化肾管中的模拟。
Adv Healthc Mater. 2018 Oct;7(19):e1800529. doi: 10.1002/adhm.201800529. Epub 2018 Aug 9.

引用本文的文献

1
Organoids: their emerging essential role in pathological mechanisms and drug discovery of diabetes and its complications.类器官:它们在糖尿病及其并发症的病理机制和药物发现中日益凸显的重要作用。
Front Pharmacol. 2025 Aug 25;16:1650200. doi: 10.3389/fphar.2025.1650200. eCollection 2025.
2
Human pluripotent stem cell-derived kidney organoids reveal tubular epithelial pathobiology of heterozygous HNF1B-associated dysplastic kidney malformations.人多能干细胞衍生的肾类器官揭示了杂合性 HNF1B 相关的发育不良性肾畸形的管状上皮病理生物学。
Stem Cell Reports. 2024 Jun 11;19(6):859-876. doi: 10.1016/j.stemcr.2024.04.011. Epub 2024 May 23.
3

本文引用的文献

1
Flow-enhanced vascularization and maturation of kidney organoids in vitro.体外增强肾类器官的血管生成和成熟。
Nat Methods. 2019 Mar;16(3):255-262. doi: 10.1038/s41592-019-0325-y. Epub 2019 Feb 11.
2
Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.肾移植后输注第三方间充质基质细胞:一项 I 期- II 期、开放性标签、临床研究。
Kidney Int. 2019 Mar;95(3):693-707. doi: 10.1016/j.kint.2018.08.046. Epub 2018 Dec 6.
3
3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening.
Functional characterization of ion channels expressed in kidney organoids derived from human induced pluripotent stem cells.
人诱导多能干细胞衍生的肾类器官中表达的离子通道的功能特征。
Am J Physiol Renal Physiol. 2022 Oct 1;323(4):F479-F491. doi: 10.1152/ajprenal.00365.2021. Epub 2022 Aug 18.
4
The term CAKUT has outlived its usefulness: the case for the prosecution.CAKUT 一词已经过时:支持起诉。
Pediatr Nephrol. 2022 Nov;37(11):2785-2791. doi: 10.1007/s00467-022-05576-4. Epub 2022 May 16.
5
Pearls and Pitfalls in Pediatric Kidney Transplantation After 5 Decades.五十年后的小儿肾移植:经验与教训
Front Pediatr. 2022 Apr 8;10:856630. doi: 10.3389/fped.2022.856630. eCollection 2022.
6
Building human renal tracts.构建人类肾脏通道。
J Pediatr Surg. 2022 Feb;57(2):172-177. doi: 10.1016/j.jpedsurg.2021.10.022. Epub 2021 Oct 29.
7
The First Thousand Days: Kidney Health and Beyond.生命最初的一千天:肾脏健康及其他
Healthcare (Basel). 2021 Oct 6;9(10):1332. doi: 10.3390/healthcare9101332.
8
The Biological Significance and Implications of Planar Cell Polarity for Nephrology.平面细胞极性对肾脏病学的生物学意义及影响
Front Physiol. 2021 Feb 26;12:599529. doi: 10.3389/fphys.2021.599529. eCollection 2021.
9
Aberrant Differentiation of Human Pluripotent Stem Cell-Derived Kidney Precursor Cells inside Mouse Vascularized Bioreactors.人多能干细胞衍生的肾前体细胞在血管化生物反应器内的异常分化。
Nephron. 2020;144(10):509-524. doi: 10.1159/000509425. Epub 2020 Aug 5.
3D 类器官衍生的人肾小球用于个性化足细胞疾病建模和药物筛选。
Nat Commun. 2018 Dec 4;9(1):5167. doi: 10.1038/s41467-018-07594-z.
4
Vascular bioengineering of scaffolds derived from human discarded transplant kidneys using human pluripotent stem cell-derived endothelium.利用人多能干细胞衍生的内皮细胞对来源于人废弃移植肾脏的支架进行血管生物工程改造。
Am J Transplant. 2019 May;19(5):1328-1343. doi: 10.1111/ajt.15200. Epub 2019 Jan 10.
5
Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration.非侵入性成像技术揭示了体内给药后细胞分布和持久性的影响因素。
Stem Cell Res Ther. 2018 Nov 28;9(1):332. doi: 10.1186/s13287-018-1076-x.
6
Comparative Analysis and Refinement of Human PSC-Derived Kidney Organoid Differentiation with Single-Cell Transcriptomics.人类多能干细胞衍生肾类器官分化的单细胞转录组学比较分析与优化。
Cell Stem Cell. 2018 Dec 6;23(6):869-881.e8. doi: 10.1016/j.stem.2018.10.010. Epub 2018 Nov 15.
7
Transition of inner cell mass to embryonic stem cells: mechanisms, facts, and hypotheses.内细胞团向胚胎干细胞的转变:机制、事实与假说。
Cell Mol Life Sci. 2019 Mar;76(5):873-892. doi: 10.1007/s00018-018-2965-y. Epub 2018 Nov 12.
8
An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.深入探讨 DNA -free 重编程方法,以生成无整合的诱导多能干细胞,用于未来的生物医学应用。
Stem Cell Rev Rep. 2019 Apr;15(2):286-313. doi: 10.1007/s12015-018-9861-6.
9
Kidney-on-a-chip: untapped opportunities.芯片上的肾脏:未开发的机遇。
Kidney Int. 2018 Dec;94(6):1073-1086. doi: 10.1016/j.kint.2018.06.034. Epub 2018 Oct 23.
10
Developing precision medicine using scarless genome editing of human pluripotent stem cells.利用人类多能干细胞的无痕基因组编辑开发精准医学。
Drug Discov Today Technol. 2018 Aug;28:3-12. doi: 10.1016/j.ddtec.2018.02.001. Epub 2018 Mar 8.